Balloon Procedure Shown To Improve Quality Of Life In People With Narrowed Mitral Heart Valves

January 27, 1998

DALLAS, Jan. 27 -- A relatively non-invasive surgical procedure, similar to balloon angioplasty, can dramatically improve the quality of life for patients who suffer from narrowed heart valves resulting from rheumatic heart disease.

In today's Circulation: A Journal of the American Heart Association, researchers in Tunisia report that percutaneous balloon mitral commissurotomy (BMC) -- which uses a balloon-tipped catheter to separate the narrowed mitral valve leaflets -- not only was safer, but was also more effective than comparable procedures. Commissurotomy is the term used for the procedure which separates the narrowed leaflets.

When this condition, known as mitral stenosis, occurs, blood does not flow completely from one chamber of the heart to another. This condition is usually the result of an episode of rheumatic fever during childhood. Rheumatic fever can damage the mitral valve in such a way that it begins to form scar tissue. As this scar tissue grows, it affects the flexibility of the valve and the edges actually begin to grow together. As this condition progresses, less and less blood can pass through the valve.

As a result, blood that remains behind can clot. Blood clots can obstruct blood vessels, setting the stage for heart attack and strokes. According to the American Heart Association, many of the 71,000 annual operations on valves are related to rheumatic heart disease.

The researchers' study involved a total of 90 patients, randomly assigned to three groups, each with 30 individuals.

A total of 93 percent of those in their study who had BMC did not have to undergo another procedure to widen the mitral valve in the seven-year follow-up.

Another 30 patients in the study had open mitral commissurotomy (OMC) -- the traditional treatment used over the past 25 years -- and 90 percent of them did not need another procedure.

In 30 other patients studied who had closed mitral commissurotomy (CMC) -- a procedure in which the surgeon uses a knife blade on the tip of his or her finger to separate the narrowing -- half needed another procedure. CMC is the oldest form of commissurotomy.

OMC involves opening the chest cavity to perform the procedure. In closed commissurotomy, the surgeon operates by "feel."

"The most striking and unsuspected finding at the beginning of the study was the excellent long-term results obtained after the balloon procedure that were, like those of the chest-opening operation, far superior to those after CMC," says lead author Mohamed Ben Farhat, M.D., of the Fattouma Bourguiba University Hospital in Tunisia.

In an editorial in today's Circulation: A Journal of the American Heart Association, Igor Palacios, M.D., an associate professor of medicine at Harvard Medical School, says that the findings support the concept that BMC, "should be the procedure of choice for the treatment of patients with rheumatic mitral stenosis who are optimal candidates" for the procedure.

None of the patients died during the seven-year follow-up.

"Our excellent survival rate is undoubtedly due to the younger age of our patients, almost all of whom were women and had favorable mitral valve anatomy," says Ben Farhat.

Of the 90 patients ranging in age from 11 to 50 years old in the study, 77 were women. In the follow-up, it was found that the area within the mitral valve increased in those patients who had BMC or OMC much more than in those with CMC. The rate of restenosis - re-narrowing of the valve - was only 6.6 percent after BMC or OMC compared to 37 percent after CMC.

According to the researchers, the lower-success rates shown in CMC are not an indictment of the surgeons who perform the procedure. Rather, they believe that technical problems in the closed techniques are to blame.

Co-authors are Mokdad Ayari, M.D.; Faouzi Maatouk, M.D.; Fethi Betbout, M.D.; Habib Gamra, M.D.; Mourad Jarrar, M.D.; Mabrouk Tiss, M.D.; Sonia Hammami, M.D.; Rafik Thaalbi, M.D.; and Faouzi Addad, M.D.



Media advisory: Dr. Mohamed Ben Farhat can be reached by phone 011 216 346 0 822 or by fax at 011 216 346 0 737. Dr. Palacios can be reached at (617) 726-8424. (Please do not publish telephone numbers.)
-end-


American Heart Association

Related Mitral Valve Articles from Brightsurf:

Aortic valve replacement during COVID-19 pandemic
The outcomes associated with deferred compared with expedited aortic valve replacement in patients with severe aortic stenosis during the COVID-19 pandemic are evaluated in this observational study.

Computational modeling enables heart valve visualizations
Computational modeling has provided new insights into the heart's vascular system, a complex and mechanically demanding system that remains poorly understood.

Comprehensive evaluation of mitral valve-in-valve and valve-in-ring
Mitral valve-in-valve (ViV) and valve-in-ring (ViR) are alternatives to surgical reoperation in patients with recurrent mitral valve failure after previous surgical valve repair or replacement.

Frailty may be highly predictive of complications, death in patients with mitral valve disease
Frailty measurements have become increasingly important in assessing surgical risk in patients with mitral valve disease, and research published online today in The Annals of Thoracic Surgery shows that frailty plays a significant role in outcomes following mitral valve procedures.

New type of heart valve may be the only replacement a child needs
Current prosthetic heart valves for children with congenital heart disease are fixed in size, requiring repeated open-heart surgeries during childhood to replace the valve with a larger version.

Innovative valve train saves 20% fuel
Empa has developed an innovative, electrohydraulically actuated valve train for internal combustion engines, that enables completely free adjustment of stroke and timing, while at the same time being robust and cost effective.

Cyborg-like microchip valve driven by earthworm muscle
Scientists at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have developed the first microchip valve powered by living cells.

Defects in heart valve cilia during fetal development cause mitral valve prolapse
Genetic mutations in heart valve cells of the developing fetus lead to mitral valve prolapse, report a global collaborative of researchers, including Medical University of South Carolina investigators, in today's Science Translational Medicine.

Echocardiograms may help with patient selection for transcatheter mitral valve repair
Clinicians should use echocardiography, an ultrasound that shows the heart's structure and function, when determining whether patients with heart failure and a leaking heart valve are likely to benefit from valve repair, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Transcatheter valve replacement safe in those with unusual valve anatomy
Compared with patients who had a typical tricuspid aortic valve, patients with a more unusual bicuspid aortic valve had a similar rate of death but a higher likelihood of stroke after undergoing a procedure to replace the valve by threading surgical equipment through an artery, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Mitral Valve News and Mitral Valve Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.